Helicobacter cinaedi bacteremia mimicking eosinophilic fasciitis in a patient with X-linked agammaglobulinemia

Hill, Alex; Byrne, Adam; Bouffard, Danielle; Luong, Me Linh; Saber, Melissa; Chapdelaine, Hugo

doi:10.1016/j.jdcr.2017.11.016

Cited by 6 publications

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Data on association between non- H. pylori Helicobacter species and extraintestinal diseases come from studies on extrahepatic cholangiocarcinoma,476 477 Parkinson’s disease,478 colorectal cancer479 and many other clinical entities, but solid associative evidence is lacking. Few case reports showed that H. cinaedi infections occur more often in immunocompromised patients 480–482. In addition, cases of bacteraemia of non- H. pylori Helicobacter species have been reported 483 484.…”

Section: Wg 5: Helicobacter Pylori and The Gut Microbiotamentioning

confidence: 99%

Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report

Malfertheiner

Mégraud

Rokkas

et al. 2022

Gut

711

842

View full text Add to dashboard Cite

Helicobacter pyloriInfection is formally recognised as an infectious disease, an entity that is now included in the International Classification of Diseases 11th Revision. This in principle leads to the recommendation that all infected patients should receive treatment. In the context of the wide clinical spectrum associated with Helicobacter pylori gastritis, specific issues persist and require regular updates for optimised management.The identification of distinct clinical scenarios, proper testing and adoption of effective strategies for prevention of gastric cancer and other complications are addressed. H. pylori treatment is challenged by the continuously rising antibiotic resistance and demands for susceptibility testing with consideration of novel molecular technologies and careful selection of first line and rescue therapies. The role of H. pylori and antibiotic therapies and their impact on the gut microbiota are also considered.Progress made in the management of H. pylori infection is covered in the present sixth edition of the Maastricht/Florence 2021 Consensus Report, key aspects related to the clinical role of H. pylori infection were re-evaluated and updated. Forty-one experts from 29 countries representing a global community, examined the new data related to H. pylori infection in five working groups: (1) indications/associations, (2) diagnosis, (3) treatment, (4) prevention/gastric cancer and (5) H. pylori and the gut microbiota. The results of the individual working groups were presented for a final consensus voting that included all participants. Recommendations are provided on the basis of the best available evidence and relevance to the management of H. pylori infection in various clinical fields.

show abstract

Section: Wg 5: Helicobacter Pylori and The Gut Microbiotamentioning

confidence: 99%

Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report

Malfertheiner

Mégraud

Rokkas

et al. 2022

Gut

711

842

View full text Add to dashboard Cite

show abstract

“…9 New cases of Helicobacter cinaedi-related bacteremia have been reported in immunocompromised patients, patients with rheumatoid arthritis and malignant lymphoma, 10 a prosthetic joint infection in an HIV-infected man, 11 X-linked agammaglobulinemia, 12 and acute gastroenteritis. The infecting strain showed resistance to macrolides and quinolones which represent the first-line antibiotic therapy for Campylobacter-like infections.…”

mentioning

confidence: 99%

“…The infecting strain showed resistance to macrolides and quinolones which represent the first-line antibiotic therapy for Campylobacter-like infections. 9 New cases of Helicobacter cinaedi-related bacteremia have been reported in immunocompromised patients, patients with rheumatoid arthritis and malignant lymphoma, 10 a prosthetic joint infection in an HIV-infected man, 11 X-linked agammaglobulinemia, 12 and acute gastroenteritis. 13 17 a thyroid abscess presenting with thyroid storm, 18 and a case of atypical Raynaud' syndrome.…”

mentioning

confidence: 99%

Review: Other Helicobacter species

Ménard

Smet

2019

Helicobacter

View full text Add to dashboard Cite

This article is a review of the most important, accessible, and relevant literature published between April 2018 and April 2019 in the field of Helicobacter species other than Helicobacter pylori. The initial part of the review covers new insights regarding the presence of gastric and enterohepatic non‐H. pylori Helicobacter species (NHPH) in humans and animals, while the subsequent section focuses on the progress in our understanding of the pathogenicity and evolution of these species. Over the last year, relatively few cases of gastric NHPH infections in humans were published, with most NHPH infections being attributed to enterohepatic Helicobacters. A novel species, designated “Helicobacter caesarodunensis,” was isolated from the blood of a febrile patient and numerous cases of human Helicobacter cinaedi infections underlined this species as a true emerging pathogen. With regard to NHPH in animals, canine/feline gastric NHPH cause little or no harm in their natural host; however they can become opportunistic when translocated to the hepatobiliary tract. The role of enterohepatic Helicobacter species in colorectal tumors in pets has also been highlighted. Several studies in rodent models have further elucidated the mechanisms underlying the development of NHPH‐related disease, and the extra‐gastric effects of a Helicobacter suis infection on brain homeostasis was also studied. Comparative genomics facilitated a breakthrough in the evolutionary history of Helicobacter in general and NHPH in particular. Investigation of the genome of Helicobacter apodemus revealed particular traits with regard to its virulence factors. A range of compounds including mulberries, dietary fiber, ginseng, and avian eggs which target the gut microbiota have also been shown to affect Helicobacter growth, with a potential therapeutic utilization and increase in survival.

show abstract

Helicobacter cinaedi-Associated Refractory Cellulitis in Patients with X-Linked Agammaglobulinemia

et al. 2020

View full text Add to dashboard Cite

Helicobacter cinaedi bacteremia mimicking eosinophilic fasciitis in a patient with X-linked agammaglobulinemia

Cited by 6 publications

References 11 publications

Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report

Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report

Review: Other Helicobacter species

Helicobacter cinaedi-Associated Refractory Cellulitis in Patients with X-Linked Agammaglobulinemia

Contact Info

Product

Resources

About